Step 3: Intellectual Property Consultation

It is possible that you may have or may develop Intellectual Property (IP) over the course of the clinical trial. Consultation and close communication with the Penn Center for Innovation is essential to protecting your IP.

For further guidance, please contact OCR Regulatory via email at psom-ind-ide@pobox.upenn.edu.